Xiaofang Xu
Nanning, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Shifting burden of inflammatory bowel disease in women of childbearing age: from high-income to low-income countries (1990-2021).
Journal: BMJ open
Published: October 14, 2025
Elevated levels of IRF1 and CASP1 as pyroptosis-related biomarkers for intestinal epithelial cells in Crohn's disease.
Journal: Frontiers in immunology
Published: December 25, 2024
Exploring the Shared Diagnostic Genes in IBD and Psoriasis through Bioinformatics and Experimental Assays.
Journal: International journal of medical sciences
Published: November 15, 2024
Correlation Of Fut2 And Fut3 Gene Polymorphisms With Inflammatory Bowel Disease In Guangxi Zhuang Population.
Journal: International journal of general medicine
Published: November 10, 2024
Butyrate attenuates intestinal inflammation in Crohn's disease by suppressing pyroptosis of intestinal epithelial cells via the cGSA-STING-NLRP3 axis.
Journal: International immunopharmacology
Published: June 19, 2024
Integrated multi-omics reveal gut microbiota-mediated bile acid metabolism alteration regulating immunotherapy responses to anti-α4β7-integrin in Crohn's disease.
Journal: Gut microbes
Published: February 05, 2024
Long-term remission achieved in a rare case of pyoderma gangrenosum and ulcerative colitis with surgery and postoperative infliximab.
Journal: Revista espanola de enfermedades digestivas
Published: January 11, 2024
Gut microbiota-related bile acid metabolism-FXR/TGR5 axis impacts the response to anti-α4β7-integrin therapy in humanized mice with colitis.
Journal: Gut microbes
Published: July 11, 2023
Comparative efficacy and safety of combination therapy with infliximab for Crohn's disease: a systematic review and network meta-analysis.
Journal: International journal of colorectal disease
Published: March 17, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026